Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Karo Bio Study Boosts Buyout Prospects From Pfizer
Karo Bio Study Boosts Buyout Prospects From Pfizer
Karo Bio Study Boosts Buyout Prospects From Pfizer
Submitted by
admin
on September 17, 2008 - 6:14am
Source:
Bloomberg
Headline:
Karo Bio Study Boosts Buyout Prospects From Pfizer
Do Not Allow Advertisers to Use My Personal information
